Geopolitical Tensions Rise as Taiwan Reaffirms Stance Following US Warning Cambria CEO Marty Davis Leverages Tariffs to Gain Competitive Advantage in Quartz Market Shenandoah Telecommunications SHEN Q1 2026 Earnings Miss by Significant Key Takeaways Creator Content Takes Center Stage at TV Upfronts as Ad Spending Surges Past 44 Billion Synopsys Reports 42 Revenue Surge from Ansys Acquisition Amid GAAP Profit Decline SP 500 Edges Up as Technology Rally Offsets Energy and HealthCare Drag Trump Delays AI Executive Order Signing Citing Concerns Over Potential Roadblocks SK Hynix Surpasses 1 Trillion Market Cap as AI Boom Drives Chip Stocks Higher Jim Cramer Investigates Adobes ADBE Strategic Position Amid AI Competition Donald Trump JrBacked Enhanced Games Set for Sunday Debut Amid Controversy and Commercial Ambitions Gap Inc Q1 2026 Earnings Earnings Miss Estimates Amid Strategic Transition WES Q1 2026 Earnings Strong Earnings Beat Drives Share Gains Exicure XCUR Q2 2022 Earnings WiderThanExpected Loss Fails to Deter Investors RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency MSC Income Fund Inc MSIF Q1 2026 Earnings EPS Slightly Misses Estimates as Fund Advances HireQuest Inc HQI Q1 2026 Earnings EPS Misses Estimate by Narrow Margin Shares Decline Belden Inc BDC Faces Selling Pressure Tests Key Support Near 102 Revolve Group RVLV Gains 423 as Bullish Momentum Builds OFS Capital Corporation OFS Holds Gains as Stock Nears Resistance Zone ZOOZW Warrants Hold Muted at 002 as Trading Remains Stagnant Highview Merger Corp HVMC Holds Steady at 1012 as Investors Await Catalysts Uranium Energy Corp UEC Gains 376 as Nuclear Sentiment Strengthens Tripcom TCOM Slides 3 as Market Sentiment Sours on Travel Demand Concerns UniFuels Holdings UFG Sheds 314 as Stock Tests Key Support Levels Schrodinger Inc SDGR Holds Steady Near Support as Momentum Builds Beta Bionics BBNX Surges 114 as Bullish Momentum Tests Key Resistance at 1241 UK Faces 325bn Dirty Money Flow Risk Report Suggests Potential Impact on Financial Sector and Crypto Regulation Kyntra Bio Inc KYNB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as Stock Edges Higher Day One Biopharmaceuticals DAWN Holds Steady at 2153 Consolidating Between Key Levels